Trials / Completed
CompletedNCT01384903
An Open-label Study of KW-3357
An Open-label Study of KW-3357 Compared to Plasma-derived Antithrombin for Disseminated Intravascular Coagulation (DIC) Associated With Infection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 221 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of KW-3357 compared to plasma-derived antithrombin using multi-center, open-label, parallel-group, comparative method in patients with Disseminated Intravascular Coagulation (DIC) associated with infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KW-3357 | Intravenous infusion once a day |
| DRUG | Plasma-derived antithrombin | Intravenous infusion once a day |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2011-06-29
- Last updated
- 2017-03-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01384903. Inclusion in this directory is not an endorsement.